News Quantified

PTN – palatin technologies, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Palatin Announces Positive Phase IIb BREAKOUT Study Results in Patients with Type 2 Diabetic Nephropathy [Yahoo! Finance]

Palatin Announces Positive Phase IIb BREAKOUT Study Results in Patients with Type 2 Diabetic Nephropathy

Palatin Announces Exercise of Warrants for Approximately $3.4 Million Gross Proceeds [Yahoo! Finance]

Palatin Announces Exercise of Warrants for Approximately $3.4 Million Gross Proceeds

Palatin Announces Completion of Patient Enrollment in Phase 2 Study of Orally Administered Melanocortin Agonist PL8177 in Ulcerative Colitis [Yahoo! Finance]

-10.8%

BEAT

-13.4%

BEAT

-23.2%

MISS

Form 8-K PALATIN TECHNOLOGIES For: Dec 13

Form 10-Q PALATIN TECHNOLOGIES For: Sep 30

Form 8-K PALATIN TECHNOLOGIES For: Nov 14

Form 424B3 PALATIN TECHNOLOGIES

Form EFFECT PALATIN TECHNOLOGIES

Top News Gainers

8/6 Palatin Technologies To Present At Canaccord Genuity's 39th Annual Growth Conference 19.5%

6/26 Form 4 PALATIN TECHNOLOGIES For: Jun 24 Filed by: Rossetti Angela 11.0%

9/12 Form 10-K PALATIN TECHNOLOGIES For: Jun 30 6.0%

5/9 Form 10-Q PALATIN TECHNOLOGIES For: Mar 31 5.3%

5/9 Palatin Technologies' (PTN) CEO Carl Spana on Q3 2019 Results - Earnings Call Transcript [Seeking Alpha] 5.2%

6/20 Form 8-K PALATIN TECHNOLOGIES For: Jun 20 3.9%

2/5 Form SC 13G/A PALATIN TECHNOLOGIES Filed by: BlackRock Inc. 2.6%

5/11 Palatin Technologies, Inc. (NASDAQ: PTN) was upgraded by analysts at BidaskClub from a "buy" rating to a "strong-buy" rating. 2.1%

11/7 Palatin Technologies, Inc. to Report First Quarter Fiscal Year 2020 Results; Teleconference and Webcast to be held on November 13, 2019 2.0%

8/7 Form 4 PALATIN TECHNOLOGIES For: Aug 05 Filed by: Hull Joseph Stanley 1.8%

Top News Decliners

6/21 FDA approves drug for loss of sexual desire in women [Reuters (UK)] -39.2%

2/10 Q2/2020 12/31/2019 EPS -0.020 ZacksConsensus 0.000 ActVsEst (0.020) - Miss -15.7%

4/30 Form PRE 14A PALATIN TECHNOLOGIES For: Jun 25 -9.8%

6/6 Palatin Technologies Granted FDA Orphan Drug Designation -- PL-8177 for the Treatment of Non-Infectious Uveitis -9.3%

7/1 Palatin Technologies Provides Mid-Calendar Year Corporate Update -8.4%

4/30 Palatin Technologies Provides Assessment of Impact of COVID-19 Pandemic on Business Operations -7.7%

9/12 Palatin Tech up 7% premarket on FY 2019 results [Seeking Alpha] -4.8%

2/6 Palatin Technologies, Inc. to Report Second Quarter Fiscal Year 2020 Results; Teleconference and Webcast to be held on February 11, 2020 -3.4%

11/1 Does Palatin Technologies (NYSEMKT:PTN) Deserve A Spot On Your Watchlist? [Yahoo! Finance News] -3.3%

9/11 Palatin Technologies, Inc. to Report Fourth Quarter & Fiscal Year End 2019 Results; Teleconference and Webcast to be held on September 12, 2019 -3.1%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day